90 related articles for article (PubMed ID: 7514714)
21. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
Lyall RM; Zilberstein A; Gazit A; Gilon C; Levitzki A; Schlessinger J
J Biol Chem; 1989 Aug; 264(24):14503-9. PubMed ID: 2788167
[TBL] [Abstract][Full Text] [Related]
22. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
Hoffman R; Dennis IF; Donaldson J
Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
[TBL] [Abstract][Full Text] [Related]
23. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
[TBL] [Abstract][Full Text] [Related]
24. Inhibition by two lavendustins of the tyrosine kinase activity of pp60F527 in vitro and in intact cells.
Agbotounou WK; Umezawa K; Jacquemin-Sablon A; Pierre J
Eur J Pharmacol; 1994 Sep; 269(1):1-8. PubMed ID: 7828651
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src.
Plé PA; Green TP; Hennequin LF; Curwen J; Fennell M; Allen J; Lambert-Van Der Brempt C; Costello G
J Med Chem; 2004 Feb; 47(4):871-87. PubMed ID: 14761189
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors.
Martin BL
Biochem Pharmacol; 1998 Aug; 56(4):483-8. PubMed ID: 9763224
[TBL] [Abstract][Full Text] [Related]
27. A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization.
Ramdas L; Obeyesekere NU; McMurray JS; Gallick GE; Seifert WE; Budde RJ
Arch Biochem Biophys; 1995 Nov; 323(2):237-42. PubMed ID: 7487083
[TBL] [Abstract][Full Text] [Related]
28. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet activation by tyrosine kinase inhibitors.
Rendu F; Eldor A; Grelac F; Bachelot C; Gazit A; Gilon C; Levy-Toledano S; Levitzki A
Biochem Pharmacol; 1992 Sep; 44(5):881-8. PubMed ID: 1382425
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of protein-tyrosine kinases by tyrphostins.
Levitzki A; Gazit A; Osherov N; Posner I; Gilon C
Methods Enzymol; 1991; 201():347-61. PubMed ID: 1658552
[No Abstract] [Full Text] [Related]
31. Evidence for two distinct 60-kilodalton substrates of the SRC tyrosine kinase.
Ogawa W; Hosomi Y; Shii K; Roth RA
J Biol Chem; 1994 Nov; 269(47):29602-8. PubMed ID: 7525585
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
Esther A; Iftach S; Esther P
FEBS Lett; 1994 Mar; 341(1):99-103. PubMed ID: 8137930
[TBL] [Abstract][Full Text] [Related]
33. Tyrphostin-induced differentiation of mouse erythroleukemia cells.
Anafi M; Gazit A; Gilon C; Neriah YB; Levitzki A
FEBS Lett; 1993 Sep; 330(3):260-4. PubMed ID: 8375496
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
Gillespie J; Dye JF; Schachter M; Guillou PJ
Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
[TBL] [Abstract][Full Text] [Related]
35. Substrate-specific modulation of Src-mediated phosphorylation of Ras and caseins by sphingosines and other substrate modulators.
Abdel-Ghany M; Osusky M; Igarashi Y; Hakomori S; Shalloway D; Racker R
Biochim Biophys Acta; 1992 Nov; 1137(3):349-55. PubMed ID: 1280164
[TBL] [Abstract][Full Text] [Related]
36. Involvement of deoxygenation-induced increase in tyrosine kinase activity in sickle cell dehydration.
Merciris P; Hardy-Dessources MD; Sauvage M; Giraud F
Pflugers Arch; 1998 Aug; 436(3):315-22. PubMed ID: 9644211
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.
Osherov N; Gazit A; Gilon C; Levitzki A
J Biol Chem; 1993 May; 268(15):11134-42. PubMed ID: 8098709
[TBL] [Abstract][Full Text] [Related]
38. Haemin enhancement of glucose transport in human lymphocytes: stimulation of protein tyrosine phosphatase and activation of p56lck tyrosine kinase.
Lander HM; Levine DM; Novogrodsky A
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):281-7. PubMed ID: 8471045
[TBL] [Abstract][Full Text] [Related]
39. Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin.
Zhan X; Plourde C; Hu X; Friesel R; Maciag T
J Biol Chem; 1994 Aug; 269(32):20221-4. PubMed ID: 7519605
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion.
Jones PM; Persaud SJ
Biochem Soc Trans; 1994 May; 22(2):209S. PubMed ID: 7525376
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
